Of the six osteoporosis performance measures relevant to internal medicine physicians, only one is valid at three levels of attribution, i.e., individual physician, group practice, and health plan, an ACP assessment found.
10 Oct 2023
A new clinical guideline from ACP focuses on pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults.
1 May 2023
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
1 Nov 2023
A 70-year-old woman is evaluated for follow-up of osteoporosis, diagnosed 5 years ago. What is the most appropriate management?
22 Nov 2022
The new clinical guideline from the College updates its 2017 recommendations on pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults.
3 Jan 2023
This month's issue addresses osteoporosis, transient ischemic attacks, and another edition of I.M. Ready columns for early career physicians.
1 May 2023
A 78-year-old woman is evaluated for osteoporosis. She was diagnosed 5 years ago following a fragility fracture in the left hip. Following medical treatment and dual-energy x-ray absorptiometry, what is the most appropriate management?
19 Apr 2022
Recent studies indicate that late-life bone resiliency has been eroding, and newly released guidelines suggest diagnostic and treatment strategies to counteract that slide among women.
1 Jan 2017
Guideline recommends pharmacologic treatment of osteoporosis in postmenopausal women at high fracture risk
Bisphosphonates are recommended for initial treatment, although ibandronate is not recommended for reducing nonvertebral or hip fracture risk, the clinical practice guideline from the Endocrine Society stated.
2 Apr 2019
Women with osteoporosis had similar mortality risk, but much higher rates of hip fracture, compared to those without osteoporosis but with other risk factors for fracture.
25 Jun 2019